Eliminating Public Health Threats: How scalable is your vaccine distribution strategy?
In the last two years, the Center for Disease Control and Prevention (CDC) has sent scientists and doctors into the field over 750 times to respond to health threats. Middle East Respiratory Syndrome (MERS), Ebola, and Avian flu are just a few of the diseases that have recently infiltrated large populations and required a global response to mitigate the risk.
In the event that there is a widespread public health outbreak, it's the responsibility of various government agencies, including the Department of Defense (DoD) and CDC, and commercial entities to sponsor research that will protect populations; ranging from the warfighter to the general public. Oftentimes these collaborations between government and industry facilitate vaccine development and distribution so that when an emergency arises they are prepared and can respond quickly.
In this blog we'll discuss three considerations when carrying out a large-scale vaccine distribution operation and the importance of a qualified deployment strategy.
Topic: Biobanking and Biorepository, Topic: Clinic..........